NLRP3 and gout: For example, soluble decoy receptor 3 (DcR3) promotes the differentiation of anti-inflammatory M2 macrophages and inhibits NLRP3 activation by reducing MSU-induced mitochondrial dysfunction and lysosomal rupture to decrease ROS production and cathepsin levels and to improve gout (102).